TNF Pharmaceuticals ( (TNFA) ) has released a notification of late filing.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
TNF Pharmaceuticals has announced a delay in filing its Annual Report on Form 10-K (Yearly Report) for the financial period ending December 31, 2024. The primary reason for this delay is the additional time required to complete and finalize the financial statements. The company anticipates that the report will be filed within 15 calendar days following the original due date. Importantly, TNF Pharmaceuticals does not expect any significant changes in its financial results for the period. The notification was signed by Joshua Silverman, Director, who assured ongoing compliance efforts.
More about TNF Pharmaceuticals
YTD Price Performance: -68.70%
Average Trading Volume: 533,938
Technical Sentiment Signal: Strong Buy
Current Market Cap: $991.8K
Find detailed analytics on TNFA stock on TipRanks’ Stock Analysis page.